Enhancement of the immune response to poorly immunogenic gangliosides after incorporation into very small size proteoliposomes (VSSP)
Authors:
- Francisco EstevezFEFrancisco Estevez
- Adriana CarrACAdriana Carr
- Leobaldo SolorzanoLSLeobaldo Solorzano
- Oscar ValienteOVOscar Valiente
- Circe MesaCMCirce Mesa
- Osquel BarrosoOBOsquel Barroso
- Gustavo Victoriano SierraGSGustavo Victoriano Sierra
- Luis Enrique FernandezLFLuis Enrique Fernandez
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- The adjuvant MF59: the 1998 perspective, clinical performance and mechanism of actionResearch in Immunology, 1998
- CD1d-Restricted and TCR-Mediated Activation of V α 14 NKT Cells by GlycosylceramidesScience, 1997
- Candidate HIV Type 1 Multideterminant Cluster Peptide-P18MN Vaccine Constructs Elicit Type 1 Helper T Cells, Cytotoxic T Cells, and Neutralizing Antibody, All Using the Same Adjuvant ImmunizationAIDS Research and Human Retroviruses, 1996
- Approaches to Augmenting the Immunogenicity of Melanoma Gangliosides: From Whole Melanoma Cells to Ganglioside‐KLH Conjugate VaccinesImmunological Reviews, 1995
- Efficacy of tumor cell vaccine after incorporating monophosphoryl lipid A (MPL) in tumor cell membranes containing tumor-associated gangliosideCellular and Molecular Life Sciences, 1994
- GD3/proteosome vaccines induce consistent IgM antibodies against the ganglioside GD3Vaccine, 1993
- Proteosome-Lipopeptide Vaccines: Enhancement of Immunogenicity for Malaria CS PeptidesScience, 1988
- Genetic Regulation of GM2 Expression in Liver of MouseThe Journal of Biochemistry, 1983
- A procedure for the quantitative isolation of brain gangliosidesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1980
- Quantitive estimation of sialic acidsBiochimica et Biophysica Acta, 1957